Webinar: Reigniting Colorectal Cancer Screening As Communities Face And Respond To The COVID-19 Pandemic
On July 23, the NCCRT hosted a discussion about our new report on colorectal cancer screening during the COVID-19 pandemic. The report, which released on June 30, provides an action-oriented playbook for how NCCRT members, 80% pledged partners, and colorectal cancer screening advocates across the nation can work together to reignite our screening efforts appropriately, safely, and equally for all communities. During this webinar, we heard from the report’s lead authors, an expert panel that shared four aligning statements as well as a summary of findings.
Speakers:
- Rachel Issaka, MD, MAS — Clinical Research Division, Fred Hutchinson Cancer Research Center; Hutchinson Institute for Cancer Outcomes Research, Fred Hutchinson Cancer Research Center; Division of Gastroenterology, University of Washington School of Medicine.
- Steven Itzkowitz, MD, FACP, FACG, AGAF — Professor of Medicine and Oncological Sciences Director, Gastroenterology Fellowship Program Icahn School of Medicine at Mount Sinai; NCCRT Steering Committee Member
- Michael Sapienza – CEO, Colorectal Cancer Alliance
- Ma Somsouk, MD, MAS, AGAF — Professor of Medicine, Division of Gastroenterology, UCSF Center for Vulnerable Populations, SF Cancer Initiative
- Richard Wender, MD — Chair, National Colorectal Cancer Roundtable; Department of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University
Explore More
The Dos and Don’ts of Colorectal Cancer Screening
NEWLY UPDATED! This cobrandable one-page flyer may be used to remind clinicians about some of the dos and don’ts when it comes to colorectal cancer screening.
Colorectal Cancer Data Dashboard
The CRC Data Dashboard is a dynamic national platform that integrates layers from multiple sources and allows you to interactively explore data using maps and graphs.
2023 Lead Time Messaging Guidebook
This Guidebook is intended to provide you with information and tools to motivate individuals at average and heightened risk for CRC to discuss screening prior to the recommended screening age. Our belief is that this will increase the likelihood that they will prioritize getting screened on-time for CRC.